Do You Really Need a DUTCH Test?

An Evidence-Based Perspective on Hormone Testing

In recent years, advanced hormone testing—particularly the DUTCH test (Dried Urine Test for Comprehensive Hormones)—has gained popularity in functional and integrative medicine circles.

Patients are often told it provides a more “complete picture” of their hormones, including estrogen metabolism and cortisol patterns.

But an important question is often overlooked:

Does this additional information actually change treatment—or improve outcomes?

At Vantage Health, our stance is simple:

Testing should guide decisions—not just generate more data.

What Is the DUTCH Test?

The DUTCH test is a dried urine assay that measures:

• Estrogen and progesterone metabolites

• Androgen metabolites

• Cortisol and cortisone patterns throughout the day

It is often marketed as a more comprehensive alternative to standard blood (serum) testing.

The Gold Standard: History + Symptoms + Serum Labs

Before discussing DUTCH testing, it’s important to understand what already works—and is widely accepted in clinical medicine.

Across endocrinology and menopause care, treatment decisions are primarily guided by:

• A detailed patient history

• A thorough symptom assessment

• Standardized serum laboratory testing

These tools are:

• Clinically validated

• Reproducible

• Used in major guidelines and clinical trials

Most importantly, they directly inform treatment decisions.

Where DUTCH Testing Falls Short

1. More Data Does Not Equal Better Care

DUTCH testing provides a large volume of additional data—especially hormone metabolites.

However:

There is limited evidence that measuring estrogen metabolites improves clinical outcomes in hormone therapy management.[1][2]

In practice, this means:

• The data may be interesting

• But it is often not actionable

  
  

2. Estrogen Metabolism: Clinically Interesting, Rarely Actionable

One of the main selling points of DUTCH testing is the analysis of estrogen metabolism pathways:

• 2-hydroxyestrone

• 4-hydroxyestrone

• 16-hydroxyestrone

While these pathways have been studied in research settings, there is:

• No strong clinical guideline recommending treatment adjustments based on these values

• No high-quality evidence that modifying these pathways improves patient symptoms or outcomes[2][3]

  
  

Key Clinical Question: Does It Change Treatment?

This is where the discussion becomes very practical.

In real-world hormone therapy, we do NOT:

• Adjust estradiol dosing (oral, transdermal, or injectable) based on urine metabolites

• Select delivery method (cream vs patch vs oral vs injection) based on DUTCH results

• Titrate progesterone based on DUTCH metabolites

Instead, we base decisions on:

• Symptom response

• Serum estradiol levels (when appropriate)

• Clinical context and safety

So what does DUTCH testing actually change?

In most cases:

Nothing meaningful in the treatment plan.

3. The DIM Question: A Common but Weak Link

Many DUTCH-based protocols recommend supplements such as diindolylmethane (DIM) to “optimize” estrogen metabolism.

However:

• Evidence supporting DIM for improving hormone-related symptoms is limited and inconsistent

• DIM is not recommended in major menopause or endocrine guidelines

• There is no strong clinical evidence that altering estrogen metabolism via supplements improves outcomes in HRT patients[4]

So if:

• We are not adjusting hormones based on DUTCH

• And we are not using evidence-based interventions to modify metabolites

Then:

The clinical utility of measuring those metabolites becomes questionable.

4. Cortisol Testing and the “Adrenal Fatigue” Problem

DUTCH testing also emphasizes cortisol rhythm patterns.

While this sounds useful, there are key limitations:

• The concept of “adrenal fatigue” is not recognized by major medical organizations[5]

• Cortisol levels are highly variable and influenced by:

  • Sleep

  • Stress

  • Illness

  • Timing inconsistencies

Most importantly:

Treatment of fatigue, stress, and burnout does not depend on DUTCH testing results.

Management still includes:

• Sleep optimization

• Nutrition

• Exercise

• Stress management

• Targeted medical therapy when appropriate

  
  

5. Cost vs. Clinical Value

DUTCH testing typically costs:

• $250–$400+ out-of-pocket

Compared to:

• Serum labs (often covered or lower cost)

If a test does not meaningfully change management, then it raises an important concern:

Are patients paying for better care—or just more information?

6. When Might DUTCH Testing Be Considered?

To be fair and balanced, there may be limited scenarios where expanded testing is explored:

• Complex or refractory cases

• Research or academic interest

• Highly individualized patient requests

However, these are exceptions—not standard care.

The Bottom Line

In hormone optimization and menopause care:

• We treat patients—not metabolites

• We adjust therapy based on symptoms and validated labs

• We prioritize interventions that are proven to work

And most importantly:

If a test does not change treatment, it does not add value.

Our Philosophy at Vantage Health

“More data isn’t better—better decisions are.”

We focus on:

• Evidence-based care

• Cost-conscious decision-making

• Treatments that actually improve how patients feel

  
  

References

1. Stanczyk FZ, Clarke NJ. Advantages and challenges of mass spectrometry assays for steroid hormones. J Steroid Biochem Mol Biol. 2010.

2. Santen RJ et al. Managing menopausal symptoms with hormone therapy. J Clin Endocrinol Metab. 2020.

3. North American Menopause Society (NAMS). 2022 Hormone Therapy Position Statement.

4. Reed GA et al. Single-dose and multiple-dose administration of diindolylmethane. Cancer Epidemiol Biomarkers Prev. 2008.

5. Endocrine Society. “Adrenal fatigue” scientific statement / position overview.